2 Dividend Stocks to Buy Hand Over Fist
Different stocks appeal to different kinds of investors. For instance, Bristol Myers Squibb (NYSE: BMY) can provide stability, safety, and predictability as it is in the business of developing lifesaving drugs and has a portfolio full of them. On the other hand, (NASDAQ: MSFT) is a stock growth-oriented investors might be interested in. The tech giant has multiple potential growth avenues to exploit over the long run.
Bristol Myers and Microsoft can both appeal to dividend investors despite their many differences. Let's find out why these stocks are great picks for income-seekers.
Bristol Myers is going through that dreaded period pharmaceutical companies fear. Its sales are dropping due to biosimilar competition for some of its former best-selling medicines. In the second quarter, the drugmaker's revenue declined by 6% year over year to $11.2 billion. Its adjusted earnings per share dropped to $1.75, which was 9% lower than the year-ago period.
Source Fool.com
Microsoft Corp. Stock
The stock is one of the favorites of our community with 151 Buy predictions and 4 Sell predictions.
With a target price of 501 € there is a slightly positive potential of 17.07% for Microsoft Corp. compared to the current price of 427.95 €.
